Purdue Announces Collaboration For 3D Printing Effort

Purdue University’s College of Pharmacy and Ohio-based Aprecia
Pharmaceuticals LLC are collaborating on future 3-D printed pharmaceutical
equipment and medications. Eric Barker, dean of the College of Pharmacy,
says the partnership will foster access to 3D printing resources for faculty
and students as well as “joint collaborations in research and discovery,
learning and teaching, engagement and technical assistance.”

“Purdue University is committed to its investment in drug discovery and
development as well as student and faculty enrichment that will continue to
yield global advancement in medicine and health care,” Barker said. “As a
college, our mission is to prepare the next generation of leaders in
pharmacy. Partnering with Aprecia aligns perfectly with that mission. We are
excited to combine our talented students and faculty with the successful
researchers at Aprecia to work together to accelerate discoveries in this
emerging field.”

The university says the partnership aims to advance the technology and
science of 3D pharmaceutical printing. Aprecia says it will help lead the
initiative with its extensive research and experience. The company also
developed the first 3D printed medication to receive FDA approval in 2015.

Eric Munson, head of the college’s Department of Industrial and Physical
Pharmacy, said that the collaboration will spur the development of advanced
medications.

“Giving our faculty and students access to 3DP technology through research
projects, internships, and joint collaborations advances our mission of
educating and training students through scientific discovery and
development,” Munson said. “Incorporating the latest technological
developments, like 3DP, into our program are key to producing the best
workforce in pharmaceutical formulation and manufacturing.”